202 related articles for article (PubMed ID: 21251205)
1. Hindered dissolution of fibrin formed under mechanical stress.
Varjú I; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K
J Thromb Haemost; 2011 May; 9(5):979-86. PubMed ID: 21251205
[TBL] [Abstract][Full Text] [Related]
2. Lytic resistance of fibrin containing red blood cells.
Wohner N; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2306-13. PubMed ID: 21737785
[TBL] [Abstract][Full Text] [Related]
3. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.
Kovács A; Szabó L; Longstaff C; Tenekedjiev K; Machovich R; Kolev K
Thromb Res; 2014 Jan; 133(1):80-7. PubMed ID: 24094605
[TBL] [Abstract][Full Text] [Related]
4. Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components.
Rottenberger Z; Komorowicz E; Szabó L; Bóta A; Varga Z; Machovich R; Longstaff C; Kolev K
J Thromb Haemost; 2013 Mar; 11(3):529-38. PubMed ID: 23279194
[TBL] [Abstract][Full Text] [Related]
5. Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.
Zamolodchikov D; Strickland S
Blood; 2012 Apr; 119(14):3342-51. PubMed ID: 22238323
[TBL] [Abstract][Full Text] [Related]
6. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
7. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones.
Longstaff C; Varjú I; Sótonyi P; Szabó L; Krumrey M; Hoell A; Bóta A; Varga Z; Komorowicz E; Kolev K
J Biol Chem; 2013 Mar; 288(10):6946-56. PubMed ID: 23293023
[TBL] [Abstract][Full Text] [Related]
8. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
[TBL] [Abstract][Full Text] [Related]
9. The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
Konings J; Hoving LR; Ariëns RS; Hethershaw EL; Ninivaggi M; Hardy LJ; de Laat B; Ten Cate H; Philippou H; Govers-Riemslag JW
Thromb Res; 2015 Aug; 136(2):474-80. PubMed ID: 26153047
[TBL] [Abstract][Full Text] [Related]
10. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
11. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
[TBL] [Abstract][Full Text] [Related]
12. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.
Mutch NJ; Engel R; Uitte de Willige S; Philippou H; Ariëns RA
Blood; 2010 May; 115(19):3980-8. PubMed ID: 20228273
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid decreases the mechanical stability, but increases the lytic resistance of fibrin matrices.
Komorowicz E; Balázs N; Varga Z; Szabó L; Bóta A; Kolev K
Matrix Biol; 2017 Nov; 63():55-68. PubMed ID: 28007568
[TBL] [Abstract][Full Text] [Related]
14. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
[TBL] [Abstract][Full Text] [Related]
15. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
Savchuk AN
Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
[TBL] [Abstract][Full Text] [Related]
16. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
Carr ME; Alving BM
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
[TBL] [Abstract][Full Text] [Related]
17. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.
Sakharov DV; Nagelkerke JF; Rijken DC
J Biol Chem; 1996 Jan; 271(4):2133-8. PubMed ID: 8567670
[TBL] [Abstract][Full Text] [Related]
18. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662
[TBL] [Abstract][Full Text] [Related]
19. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
Front Immunol; 2019; 10():2967. PubMed ID: 31921206
[No Abstract] [Full Text] [Related]
20. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.
Sasajima T; Takano Y; Hiraishi Y; Goh K; Inaba M; Azuma N; Sasajima Y; Yamazaki K; Yamamoto H
J Vasc Surg; 2000 Aug; 32(2):374-82. PubMed ID: 10917998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]